Tag: semaglutide-containing drugs
-
GLP-1 Lawsuits Involving NAION Filed in Federal Court: 200 Cases as of August 2026
Patients Using Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound Seek Legal Compensation for Vision Loss (Posted by Tom Lamb at Drug Injury Watch) In December 2025, GLP-1 lawsuits involving NAION filed in federal court were consolidated by the…
-
Semaglutide-associated Vision Loss Due to NAION – New Medical Report, May 2026
Ozempic, Wegovy, and Rybelsus Are Semaglutide Drugs Linked to Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) (Posted by Tom Lamb at Drug Injury Watch) Before we direct you to a new medical report about semaglutide-associated vision loss due…
-
Ozempic And Other GLP-1RA Use Associated With NAION Eye Side Effect
New 2026 Medical Article Published By JAMA Network Open Investigates Drug Safety Issue (Posted by Tom Lamb at Drug Injury Watch) An increasingly known but still-developing drug safety issue is that of Ozempic and other GLP-1RA use…
-
While Rybelsus Pills Are Being Replaced With Pills Called Ozempic, Semaglutide NAION Risk Remains
But the January 2026 Rybelsus-Ozempic Drug Label Still Has No Warnings for NAION Vision Loss Side Effect (Posted by Tom Lamb at Drug Injury Watch) The “Revised: 1/2026” Prescribing Information document for “RYBELSUS and OZEMPIC tablets” caused…
-
Risk of NAION With Semaglutide Medicines is 2 Times Higher Than SGLT2i Diabetes Drugs
2026 Medical Article Links NAION to Ozempic, Wegovy, and Rybelsus, Again, With New Study (Posted by Tom Lamb at Drug Injury Watch) This drug safety issue of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide-containing drugs…
-
Wegovy and Ozempic Patients Get Compensation for NAION Vision Loss In Europe
Because Semaglutide is Linked to NAION, Wegovy and Ozempic Drug Injury Cases Have Been Filed In the US (Posted by Tom Lamb at Drug Injury Watch) For more than a year now, we have been looking into…
-
More Evidence For Increased Risk of NAION With Ozempic or Mounjaro in Diabetes Patients
NAION is Likely Associated With Other Semaglutide or Tirzepatide GLP-1RA Drugs Used for Weight Loss (Posted by Tom Lamb at Drug Injury Watch) A new medical article published August 11, 2025, online by JAMA Network…
-
Current FDA Safety Investigation: NAION With Mounjaro, Zepbound, and Other GLP-1 RAs
Evaluating Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Possible Risk of NAION Side Effects (Posted by Tom Lamb at Drug Injury Watch) The FDA has been investigating "potential signals" of non-arteritic anterior ischemic optic neuropathy (NAION)…